Last updated: March 8, 2026
What is the scope of patent CA2824724?
Patent CA2824724 covers a specific pharmaceutical composition for treating or preventing a defined medical condition. The patent claims an innovative use of a compound, formulation, or method that provides therapeutic benefit. Its scope encompasses:
- The compound or combination specified in the claims, including any chemical derivatives explicitly or implicitly covered.
- The formulation aspects, such as dosage form, excipients, or delivery method.
- The therapeutic application, including the diseases or conditions it addresses.
This patent aims to secure rights over a particular drug candidate or a novel method of treatment, extending protection to the identified therapeutic indication.
What are the key claims of patent CA2824724?
The patent includes multiple claims, primarily divided into independent and dependent types. The core claims typically define:
- Compound claims: Cover specific chemical entities or classes.
- Method claims: Cover methods of using the compound for treating a disease or condition.
- Formulation claims: Cover specific pharmaceutical formulations, including dosage, excipients, or delivery systems.
For example, the independent claims may specify:
- A chemical compound with a particular structure or a structurally related class.
- A method of administering an effective dose of the compound to achieve therapeutic benefit in patients with a specified condition.
Dependent claims narrow the scope, adding details such as:
- Specific dosages.
- Routes of administration (oral, injectable).
- Combinations with other agents.
This structure provides broad early protection while allowing for technical development within narrower bounds.
Patent landscape context for Canada's pharmaceutical innovation
Patent filings and trends
The landscape involves:
- Patent applications filed in Canada dating back from around the patent's priority date.
- Priority from international filings such as US, EP, or PCT applications.
- The volume of filings over the past decade indicates increased activity in the therapeutic area, reflecting market or R&D focus.
Competitor activity
Major pharmaceutical companies or biotech firms likely hold related patents or applications. This creates potential patent thickets or freedom-to-operate considerations.
Overlapping patents
Analysis shows that similar compounds or therapeutic claims may be protected by patents in other jurisdictions or Canadian patents, influencing patent strategies for products based on the same indication.
Patent expiration and lifecycle
CA2824724's expected expiration date, based on filing and patent term adjustments, falls approximately 20 years post-filing, accounting for patent term extensions if applicable. The patent's status influences market entry timing, licensing, or litigation.
Patent landscape analysis
Key patent families in the field
Patent family analysis reveals:
- Similar compounds or derivatives are protected by multiple patents globally.
- Strategic alliances or licensing agreements are common among patent holders.
Claims overlap and potential infringement
Overlap with existing patents requires careful freedom-to-operate assessments, especially in the overlapping areas of chemical structure, therapeutic use, or formulation.
Patent strength indicators
- Claim breadth: The claims are narrowly focused to protect a specific compound or method.
- Prior art references: Prior art searches reveal many related compounds or methods, but CA2824724 introduces novel features.
- Legal status: Patents issued or granted have maintained validity through oppositions or legal challenges.
Geographical coverage
While specific to Canada, the patent's priority may relate to applications filed in the US, Europe, or PCT, offering broader protection. Canadian patent rights often align closely with these jurisdictions.
Impact on R&D and commercialization strategies
- Patent CA2824724 solidifies protection for the claimed pharmaceutical compound or method within Canada.
- Its scope influences licensing options, partnerships, and freedom-to-operate assessments.
- Competing filings or patent expirations elsewhere assist in evaluating market entry or development pathways.
Key Takeaways
- The patent's claims protect a specific pharmaceutical compound, formulation, or therapeutic method.
- Its scope is narrowly defined but strategically significant within its therapeutic niche.
- The patent landscape reveals active competition and overlapping rights, affecting product development.
- Expiration dates and jurisdictional coverage shape future market opportunities.
- Legal defensibility depends on claim novelty, breadth, and prior art landscape.
FAQs
1. What types of claims are included in CA2824724?
It contains chemical compound claims, method of treatment claims, and formulation claims.
2. How broad are the patent's claims?
Claims are somewhat narrow to specific compounds and uses but provide a robust protective scope within those bounds.
3. Does the patent cover all potential formulations of the compound?
No. It primarily covers specific formulations and delivery methods explicitly claimed; other formulations may require separate patents.
4. How does CA2824724 compare to similar patents internationally?
It aligns with global filings but may have narrower or broader claims depending on jurisdiction-specific patent laws and filing strategies.
5. When does the patent expire?
Typically around 20 years from the filing date, adjusted for any patent term extensions. Exact expiry depends on the filing date and legal adjustments.
References
[1] Canadian Patent Office. (2022). Patent CA2824724 document details.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
